DECOFI sprl, represented by Mr Philip Devine, MBA, CPA, Chief Financial Officer and Interim Chief Executive Officer

Mr. Devine joined OncoMethylome Sciences at its inception. Prior to joining OncoMethylome Sciences, Mr. Devine served as chief financial officer of Tibotec-Virco, where he managed its sale to Johnson and Johnson. Previously, he was a manager at the management consulting firm McKinsey & Company and an auditor at Deloitte & Touche, where he conducted numerous mergers and acquisitions, led initial public offerings, and managed the growth of both small and Fortune 500 companies.

Mr. Devine, an American citizen, holds a CPA license, an MBA degree from INSEAD, an MSA degree from Bentley College, and a BA degree from Dartmouth College.